| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 3 |
| 1 | AZATHIOPRINE | 2 |
| 2 | METHYLPREDNISOLONE | 2 |
| 3 | PEMBROLIZUMAB | 2 |
| 4 | ABEMACICLIB | 1 |
| 5 | AFATINIB | 1 |
| 6 | AMLODIPINE | 1 |
| 7 | AVAPRITINIB | 1 |
| 8 | BASILIXIMAB | 1 |
| 9 | BEVACIZUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAZEMETOSTAT | 1 | 0.0006 |
| 1 | SELUMETINIB | 1 | 0.0006 |
| 2 | ENTRECTINIB | 1 | 0.0006 |
| 3 | AFATINIB | 1 | 0.0002 |
| 4 | ENFORTUMAB VEDOTIN | 1 | 0.0001 |
| 5 | DASATINIB | 1 | 0.0001 |
| 6 | REGORAFENIB | 1 | 0.0001 |
| 7 | BASILIXIMAB | 1 | 0.0001 |
| 8 | CRIZOTINIB | 1 | 0.0001 |
| 9 | SIROLIMUS | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 1 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 3 | Purine Antimetabolite [EPC] | 2 | 0.0000 |
| 4 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Thiazide Diuretic [EPC] | 1 | 0.0000 |
| 7 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 8 | Corticosteroid [EPC] | 5 | 0.0000 |
| 9 | Kinase Inhibitor [EPC] | 2 | 0.0000 |